VIB Accelerates Therapeutic Biologics Discovery with Geneious Biologics


Nov 12, 2018--Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been chosen by the VIB to support therapeutic biologics discovery at its Discovery Sciences group. Bruno Dombrecht, Expert Scientist at VIB Discovery Sciences: "Geneious Biologics will help us scale-up our screening efforts.



from Biotech News